Despite a recent 45% rally, I maintain a 'Sell' view on CVS due to its underwhelming execution record and rising leverage ...

CVS Health (NYSE:CVS – Free Report) had its price target lifted by JPMorgan Chase & Co. from $80.00 to $81.00 in a report ...

We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...

CVS Health stock received a positive adjustment to its Relative Strength (RS) Rating, from 70 to 73. Please watch the video ...

In this article, we will look at the 10 Best Performing Healthcare Stocks So Far in 2025.

As healthcare spending continues to rise and regulatory pressure intensifies, companies like CVS Health CVS find themselves ...

"CVS Health is leveraging Azure as more than just ... "60% of respondents said public health and welfare is the top positive societal impact of digital transformation." In other words ...

CVS Health said on Friday it has cut bonuses for some employees because of its low profit levels last year, as the healthcare ...

Bearish flow noted in CVS Health (CVS) with 13,937 puts trading, or 2x expected. Most active are Mar-25 60 puts and Feb-25 63 puts, with total ...

CVS Health Corp. cut bonuses for some employees because of last year’s low profit levels, a sign that the healthcare conglomerate is still trying to recover from setbacks that led up to the ouster of ...

Companies inform investors of possible business risks from Trump's government changes, tucking warnings into extensive "risk factor" sections of filings, contrasting with their publicly positive ...

In a report released on February 14, Steven Silver from Argus Research maintained a Buy rating on CVS Health (CVS – Research Report). The ...